IDEAS home Printed from https://ideas.repec.org/p/osf/socarx/hbs8j.html
   My bibliography  Save this paper

The Global Pharmaceutical Sector: numbers and dynamics

Author

Listed:
  • Stacciarini, João Henrique Santana

    (Federal University of Goiás)

Abstract

Researchers from various fields of scientific knowledge have dedicated efforts to investigate the multiple characteristics of the pharmaceutical sector. Aiming to contribute to this debate and provide material for discussion, this research focused on collecting, interpreting, and making available data and information related to the Pharmaceutical Sector on a global scale. It was found that the sector's annual revenue has almost quadrupled over the last two decades, reaching $1.48 trillion in 2022. The twenty largest companies have a combined market value of $3.5 trillion, assets worth $1.86 trillion, and generated revenue of $820 billion, resulting in profits of $181.6 billion. Of an oligopolistic nature, most of the leading companies are concentrated in the USA and Europe, although a group of industries in "pharmerging countries", especially in Asia, has been gaining strength. Pharmaceutical consumption, although still highly concentrated in developed countries, has also been expanding in emerging countries. This trend is driven by nations such as Brazil, Russia, India, China, and South Africa (BRICS), as well as Mexico, Indonesia, South Korea, and Turkey (MIST). Together, these nine countries already account for 48% of the world's population and contribute 31% to the global Gross Domestic Product (GDP).

Suggested Citation

  • Stacciarini, João Henrique Santana, 2025. "The Global Pharmaceutical Sector: numbers and dynamics," SocArXiv hbs8j, Center for Open Science.
    • Handle: RePEc:osf:socarx:hbs8j
    DOI: 10.31219/osf.io/hbs8j
    as

    Download full text from publisher

    File URL: https://osf.io/download/6784133b7cffd319ef3416d6/
    Download Restriction: no
    File URL: https://libkey.io/10.31219/osf.io/hbs8j?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Franco Malerba & Luigi Orsenigo, 2015. "The evolution of the pharmaceutical industry," Business History, Taylor & Francis Journals, vol. 57(5), pages 664-687, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Patricia Laurens & Christian Le Bas & Antoine Schoen, 2019. "Worldwide IP coverage of patented inventions in large pharma firms: to what extent do the internationalisation of R&D and firm strategy matter?," Post-Print hal-01725229, HAL.
    2. Hao Tan, 2017. "Making impact through industry-focused research: An Asia Pacific perspective," Asia Pacific Journal of Management, Springer, vol. 34(3), pages 487-503, September.
    3. Daniel P. Gross & Bhaven N. Sampat, 2022. "Crisis Innovation Policy from World War II to COVID-19," Entrepreneurship and Innovation Policy and the Economy, University of Chicago Press, vol. 1(1), pages 135-181.
    4. Juha‐Antti Lamberg & Mirva Peltoniemi, 2020. "The nanoeconomics of firm‐level decision‐making and industry evolution: Evidence from 200 years of paper and pulp making," Strategic Management Journal, Wiley Blackwell, vol. 41(3), pages 499-529, March.
    5. Camille Loir & Bertrand Groslambert, 2023. "The impact of innovation on the profitability of the biotech industry," Economics Bulletin, AccessEcon, vol. 43(3), pages 1286-1297.
    6. Mayimele, Nsovo & Demana, Patrick & Keele, Mothobi, 2023. "Perceptions of Board Members on the Presence of Pharmacists as Strategic Leaders of Manufacturing Pharmaceutical Companies Operating in South Africa: A Qualitative Study," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 7(2), pages 87-98.
    7. Alexander S. Kritikos & Alexander Schiersch & Caroline Stiel, 2022. "The productivity shock in business services," Small Business Economics, Springer, vol. 59(3), pages 1273-1299, October.
    8. Dosi, Giovanni & Palagi, Elisa & Roventini, Andrea & Russo, Emanuele, 2023. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Journal of Economic Behavior & Organization, Elsevier, vol. 212(C), pages 564-589.
    9. Alessandro Nuvolari & Emanuele Russo, 2019. "Technical progress and structural change: a long-term view," LEM Papers Series 2019/17, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
    10. Stacciarini, João Henrique Santana, 2025. "Investigación y Desarrollo (I+D) en el Sector Farmacéutico: avances, limitaciones, selectividad y negligencia," SocArXiv vbxzs, Center for Open Science.
    11. Pooja Thakur-Wernz & Olga Bruyaka, 2017. "Co-evolutionary Perspective on Sourcing Portfolios: Examining Sourcing Choices for Clinical Trials of Bio-pharmaceutical Firms," Management International Review, Springer, vol. 57(6), pages 909-946, December.
    12. Wu, Qiang & He, Qile, 2020. "DIY Laboratories and business innovation ecosystems: The case of pharmaceutical industry," Technological Forecasting and Social Change, Elsevier, vol. 161(C).
    13. Fukuyama, Hirofumi & Matousek, Roman & Tzeremes, Nickolaos G., 2023. "Estimating the degree of firms’ input market power via data envelopment analysis: Evidence from the global biotechnology and pharmaceutical industry," European Journal of Operational Research, Elsevier, vol. 305(2), pages 946-960.
    14. repec:ehu:cuader:49122 is not listed on IDEAS
    15. Seung In Um & Changone Kim & Taejin Ha & Jinju Kim & Heesang Lee, 2022. "Morphological Change and Internal Growth Factors of Firms in the Korean Pharmaceutical Industry in Recent Decades," Sustainability, MDPI, vol. 14(22), pages 1-19, November.
    16. Changhyeon Song & Kwangsoo Shin, 2019. "Business Model Design for Latecomers in Biopharmaceutical Industry: The Case of Korean Firms," Sustainability, MDPI, vol. 11(18), pages 1-15, September.
    17. Miozza, Mario & Brunetta, Federica & Appio, Francesco Paolo, 2024. "Digital transformation of the Pharmaceutical Industry: A future research agenda for management studies," Technological Forecasting and Social Change, Elsevier, vol. 207(C).
    18. Boutillier, Sophie & Laperche, Blandine & Lebert, Didier & Elouaer-Mrizak, Sana, 2023. "A systemic analysis of the technological trajectory at company level based on patent data: The case of Sanofi's vaccine technology," Technovation, Elsevier, vol. 124(C).
    19. Angelo Kenneth S. Romasanta & Peter Sijde & Jacqueline Muijlwijk-Koezen, 2020. "Innovation in pharmaceutical R&D: mapping the research landscape," Scientometrics, Springer;Akadémiai Kiadó, vol. 125(3), pages 1801-1832, December.
    20. Agustí Segarra‐Blasco & Mercedes Teruel & Sebastiano Cattaruzzo, 2024. "The international trade in human vaccines before COVID‐19," The World Economy, Wiley Blackwell, vol. 47(5), pages 1978-2008, May.
    21. Massimo Florio & Simona Gamba, 2021. "Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly," Annals of Public and Cooperative Economics, Wiley Blackwell, vol. 92(3), pages 387-409, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:osf:socarx:hbs8j. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: OSF (email available below). General contact details of provider: https://arabixiv.org .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.